Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?

Streptococcus pyogenes is commonly believed to be resistant to trimethoprim-sulfamethoxazole (SXT), resulting in reservations about using SXT for skin and...

Research

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group

Medulloblastoma is curable in approximately 70 % of patients. Over the past decade, progress in improving survival using conventional therapies has stalled...

News & Events

Understanding anxiety around uncertainty

In this blog, research project co-ordinator Rebecca Kuzminski discusses anxiety related to uncertainty, why this is a particular challenge for many autistic children, and new research CliniKids is conducting to help parents support their child with managing uncertainty-related anxiety.

News & Events

Supporting siblings of autistic children

In this new blog, Senior Clinical Psychologist Rebecca Eaton offers families advice on how to support siblings of autistic children.

News & Events

New autism guideline a lifeline for families

Professor Andrew Whitehouse tells how Australia’s first national guideline for the diagnosis of autism spectrum disorder is going to transform the way the condition is assessed and managed, vastly improving the experience for families.

News & Events

Heatwave health: How to protect your family during extreme heat

With Perth and WA’s south-west in the grip of several days of extreme heat, The Kids Research Institute Australia experts share their top tips on keeping your children safe in the hot weather.

News & Events

Nutrition and COVID-19

Nutrition is important during the COVID-19 pandemic because it can provide both physical and mental health benefits.

Annual Report 2023

The Kids Research Institute Australia's annual report highlights the accomplishments of our researchers, furthering our mission to secure a happier, healthier future for kids everywhere.

Research

COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement

The Australian Technical Advisory Group on Immunisation and New Zealand Ministry of Health recommend all children aged ≥ 5 years receive either of the two mRNA COVID-19 vaccines: Comirnaty (Pfizer), available in both Australia and New Zealand, or Spikevax (Moderna), available in Australia only. Both vaccines are efficacious and safe in the general population, including children. Children and adolescents undergoing treatment for cancer and immunosuppressive therapy for non-malignant haematological conditions are particularly vulnerable, with an increased risk of severe or fatal COVID-19.

Research

Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccines among pregnant women (the EPIC study): study protocol

Influenza and COVID-19 infections during pregnancy may have serious adverse consequences for women as well as their infants. However, uptake of influenza and COVID-19 vaccines during pregnancy remains suboptimal. This study aims to assess the effectiveness of a multi-component nudge intervention to improve influenza and COVID-19 vaccine uptake among pregnant women.